Acquisition by Carr Douglas of 17007 shares of Century Therapeutics subject to Rule 16b-3

IPSC Stock  USD 1.05  0.12  10.26%   
About 67% of Century Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Century Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Century Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Century Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Century Therapeutics Officer: Svp Finance & Operations. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Century insider trading alert for acquisition of common stock by Carr Douglas, Officer: Svp Finance & Operations, on 7th of June 2024. This event was filed by Century Therapeutics with SEC on 2024-06-07. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Century Therapeutics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Century Therapeutics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Century Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Century Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Century Therapeutics Fundamental Analysis

We analyze Century Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Century Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Century Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Insiders

Shares Owned By Insiders Comparative Analysis

Century Therapeutics is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Century Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Century Therapeutics stock to make a market-neutral strategy. Peer analysis of Century Therapeutics could also be used in its relative valuation, which is a method of valuing Century Therapeutics by comparing valuation metrics with similar companies.

Peers

Century Therapeutics Related Equities

GBIOGeneration Bio   5.88   
0%
61.0%
KZRKezar Life   3.66   
0%
38.0%
STOKStoke Therapeutics   1.71   
0%
17.0%
MLYSMineralys Therapeutics,   1.63   
0%
16.0%
RLAYRelay Therapeutics   1.43   
0%
14.0%
EWTXEdgewise Therapeutics   0.53   
5.0%
0%
KROSKeros Therapeutics   1.23   
12.0%
0%
ERASErasca   1.61   
16.0%
0%
BPMCBlueprint Medicines   3.11   
32.0%
0%
NKTXNkarta   4.41   
45.0%
0%
CGEMCullinan Oncology   6.27   
65.0%
0%
GLUEMonte Rosa   7.40   
76.0%
0%
PASGPassage Bio   8.96   
93.0%
0%
CCCCC4 Therapeutics   9.63   
100.0%
0%

Complementary Tools for Century Stock analysis

When running Century Therapeutics' price analysis, check to measure Century Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Century Therapeutics is operating at the current time. Most of Century Therapeutics' value examination focuses on studying past and present price action to predict the probability of Century Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Century Therapeutics' price. Additionally, you may evaluate how the addition of Century Therapeutics to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals